Titan Medical Inc

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is headquartered in Toronto, Canada.

TORONTO, Ontario, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company, announced today that the Company has entered into a licensing agreement (“Agreement”) with Auris Health, Inc., (“Auris Health”), a Johnson & Johnson MedTech company, in respect of certain intellectual property (“IP”) of Titan. Under the Agreement, Titan has granted Auris Health a non-exclusive license to a portion of Titan's IP.

Titan Medical Signs License Agreement with Auris Health, Inc.

TORONTO, Ontario, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today the appointment of Dr. Daniel O'Brien, MD, MBA, PhD to its Board of Directors. Dr. O'Brien will also serve on the Audit Committee of the Board.

Titan Medical Announces Appointment of New Independent Member to its Board of Directors

TORONTO, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today financial results for the three and six months ended June 30, 2023.

Titan Medical Reports Operating and Financial Results for the Second Quarter 2023

TORONTO, Ontario, July 04, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company, today announced the voting results from the Company's Annual General Meeting of its shareholders held on June 30, 2023.

Titan Medical Reports Voting Results From Annual General Meeting of Shareholders

TORONTO, Ontario, June 20, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is pleased to provide this further corporate update on its successful transition to an IP licensing company.

Titan Medical Successfully Transitions to an IP Licensing Company

TORONTO, Ontario, June 16, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), reports that the management cease trade order granted on April 3, 2023 (the “MCTO”) by the Ontario Securities Commission under National Policy 12-203 – Management Cease Trade Orders lapsed on June 13, 2023 following the filing, on May 31, 2023, of the Company's annual financial statements and accompanying management's discussion and analysis for the fiscal year ended December 31, 2022 and the filing, on June 9, 2023, of the Company's first quarter financial statements and accompanying management's discussion and analysis for the period ended March 31, 2023.

Titan Medical Announces Lifting of Management Cease Trade Order

TORONTO, Ontario, June 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today financial results for the three months ended March 31, 2023.

Titan Medical Reports Operating and Financial Results for the First Quarter 2023

TORONTO, Ontario, June 05, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), a medical technology company headquartered in Toronto, Ontario, announced today that the Company has entered into an asset purchase and license agreement (“Agreement”) with Medtronic (NYSE: MDT), a global leader in healthcare technology, for an upfront payment of US$8.0 million in respect of certain intellectual property (“IP”) of Titan.

Titan Medical Signs Asset Purchase and License Agreement with Medtronic

TORONTO, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today the financial results for the three and twelve months ended December 31, 2022. The Company also announced that its 2023 annual meeting (the “Meeting”) is scheduled for Friday, June 30, 2023 at 4:00 pm E.T. to be held virtually at https://web.lumiagm.com/420568592.

Titan Medical Reports Operating and Financial Results for the Fourth Quarter and Year End 2022 and Announces Availability of Materials for the 2023 Annual Meeting of Shareholders

TORONTO, Ontario, May 29, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) announced today a corporate update and is also providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).

Titan Medical Announces Corporate Update and Provides Bi-Weekly MCTO Status Update

TORONTO, Ontario, May 26, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) announced today that the Company has entered into a license agreement (“Agreement”) with Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (“RAS”), for an upfront payment of US$7.5 million in respect of certain intellectual property (“IP”) of Titan.

Titan Medical Signs License Agreement with Intuitive Surgical

TORONTO, Ontario, May 19, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) today announces that, as a result of a delay in filing its annual financial statements, the related management's discussion and analysis and annual information form, and the accompanying chief executive officer and chief financial officer certification for its financial year ended December 31, 2022 (collectively, the “Annual Filing Documents”), the Company will also be delayed in the filing of its financial statements, the related management's discussion and analysis and the accompanying chief executive officer and chief financial officer certification for its first quarter ended March 31, 2023 (the “Q1 Filing Documents”) and now expects to file the Q1 Filing Documents by June 9, 2023. As announced on May 15, 2023, the Company expects to file the Annual Filing Documents by May 31, 2023.

Titan Medical Announces Delay in First Quarter 2023 Filings

News for Titan Medical Inc Stock (TMDIF)